Pioneering New Therapy for Depression
by Linda Sechrist According to the Depression and Bipolar Support Alliance, depression affects approximately 14.8 million American adults every year, or about 6.7 percent of the U.S. population age 18 and older. “When I do the
by Linda Sechrist
According to the Depression and Bipolar Support Alliance, depression affects approximately 14.8 million American adults every year, or about 6.7 percent of the U.S. population age 18 and older. “When I do the math for Boise on how many individuals suffer depression, I should be treating 700 people a day,” says Dr. David Kent, a full-time private practice adult psychiatrist who received his medical degree and psychiatric training at the University of Iowa Hospitals and Clinics in his hometown of Iowa City.
In 1990, Kent, owner of Treasure Valley TMS of Boise, and his family moved here and set up practice. He is currently affiliated with Intermountain Hospital of Boise, St. Alphonsus Regional Medical Center, St. Luke’s Regional Medical Center and Southwest Idaho Advanced Care Hospital. Kent served as medical director for 16 years at Sun Health Hospital of Boise (now Safe Haven) and is presently the director of the partial hospitalization program at Intermountain Hospital. Kent has had leadership roles at Intermountain Hospital and St. Alphonsus Regional Medical Center.
An active owner and cofounder of Sage Health Care, Kent is Boise’s pioneer of transcranial magnetic stimulation (TMS) therapy, which uses intense magnetic pulses aimed at a particular part of the brain to induce a burst of electrical activity, stimulating the its nerve cells. This U.S. Food and Drug Administration-approved, noninvasive procedure has been shown to improve symptoms of depression, even when more traditional depression treatments such as antidepressant drugs have failed. “Approximately two-thirds of patients experience complete remission, and another 25 percent show a significant decrease in symptoms,” says Kent, who is using Brainsway Deep TMS, the second generation of the original TMS technology.
During a Brainsway Deep TMS Therapy session, a cushioned helmet containing an electromagnetic coil is placed on the patient’s head, sending a painless magnetic pulse that stimulates the region of the brain involved in mood regulation. This treatment involves daily 20-minute treatments (excluding weekends) for six to eight weeks. The majority of patients see dramatic improvement after four weeks of daily weekday treatments. Unlike other antidepressant alternatives, TMS therapy does not require hospitalization or anesthesia, and entails no memory loss.
“Brainsway Deep TMS participated in 60 clinical trials globally. In a multi-center study for treating treatment-resistant depression enrolling 230 patients, TMS was proven to have a substantial positive effect on depressive symptoms. Deep TMS is also applicable for brain disorders such as Parkinson’s disease, autism, stroke rehabilitation and smoking cessation. Brainsway continues to perform ongoing research for deep TMS,” advises Kent.
Treasure Valley TMS of Boise is located at 413 N. Allumbaugh St., Ste. 102, in Boise. For more information, call 208-954-5591 or visit TvTms.com.